Bernstein starts Carl Zeiss Meditec with 'Underperform'
The US analyst firm Bernstein Research has added Carl Zeiss Meditec to its rating with an Underperform and a price target of 76 euros. The ophthalmology market is attractive, wrote analyst Susannah...